- Home
- TAK vs CNQ Comparison
TAK vs CNQ Comparison
Compare TAK & CNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- CNQ
- Stock Information
- Founded
- TAK 1781
- CNQ 1973
- Country
- TAK Japan
- CNQ Canada
- Employees
- TAK N/A
- CNQ N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- CNQ
- Sector
- TAK Health Care
- CNQ
- Exchange
- TAK Nasdaq
- CNQ Nasdaq
- Market Cap
- TAK 42.2B
- CNQ 34.1B
- IPO Year
- TAK N/A
- CNQ 1976
- Fundamental
- Price
- TAK $15.04
- CNQ $28.69
- Analyst Decision
- TAK
- CNQ Buy
- Analyst Count
- TAK 0
- CNQ 2
- Target Price
- TAK N/A
- CNQ $60.00
- AVG Volume (30 Days)
- TAK 1.5M
- CNQ 8.1M
- Earning Date
- TAK 05-08-2025
- CNQ 03-06-2025
- Dividend Yield
- TAK 3.39%
- CNQ 5.48%
- EPS Growth
- TAK 15.39
- CNQ N/A
- EPS
- TAK 0.83
- CNQ 1.98
- Revenue
- TAK $29,124,927,177.00
- CNQ $24,781,073,642.00
- Revenue This Year
- TAK $8.53
- CNQ $8.65
- Revenue Next Year
- TAK N/A
- CNQ $0.73
- P/E Ratio
- TAK $36.00
- CNQ $14.48
- Revenue Growth
- TAK 9.83
- CNQ N/A
- 52 Week Low
- TAK $12.58
- CNQ $25.62
- 52 Week High
- TAK $15.22
- CNQ $41.29
- Technical
- Relative Strength Index (RSI)
- TAK 70.24
- CNQ 45.62
- Support Level
- TAK $14.83
- CNQ $27.76
- Resistance Level
- TAK $15.22
- CNQ $29.45
- Average True Range (ATR)
- TAK 0.17
- CNQ 0.95
- MACD
- TAK 0.03
- CNQ 0.14
- Stochastic Oscillator
- TAK 84.84
- CNQ 68.07
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About CNQ Canadian Natural Resources Limited
Canadian Natural Resources Ltd is an independent crude oil and natural gas exploration, development, and production company. The Company's exploration and production operations are focused in North America, largely in Western Canada; the United Kingdom (UK) portion of the North Sea, and Cote d'Ivoire and South Africa in Offshore Africa. The Company's exploration and production activities are conducted in three geographic segments: North America, the North Sea, and Offshore Africa. These activities include exploring, developing, producing, and marketing crude oil, natural gas liquids, and natural gas. The company has two divisions; Oil Sands Mining and Upgrading, Midstream and Refining. It derives a majority of its revenue from North America.